Mark Kidd

[Kambiz Rahbar, MD @Dr_K_Rahbar]

PROSTest: a groundbreaking multigenomic liquid biopsy for prostate cancer detection in whole blood. the PROSTest exhibited an 85% sensitivity and 95% specificity for PCa versus controls. In two independent sets, the metrics were 92%–95% sensitivity and 100% specificity.

[Mark Kidd @RNAnexus]

Brilliant! @WrenLabs @RonnyAllan1 @AmanChauhanMD @HKennecke @cives_mauro @NANETS1 @netcancerfound @PamelaKunzMD @Dr_K_Rahbar

[Wren Laboratories @WrenLabs]

Thank you @ChrisMurphyCT for recognizing @WrenLabs and our at home #COVID19 testing as the innovator of the month. https://t.co/JbbOXl0DsE

[Mark Kidd @RNAnexus]

Truly targeted therapy! And don’t forget : biomarkers to predict the target will be hit. Get beyond imaging...@AmanChauhanMD

[Aman Chauhan @AmanChauhanMD]

Thanks @lisayentwin Always great to see you in the webinars. I might be biased, but Radioligand Therapy (RLT) is the future!! @UKMarkey

[Mark Kidd @RNAnexus]

Just in time for the Holidays! A saliva-based test to keep you safe!

[Wren Laboratories @WrenLabs]

Wren Labs’ >99% accurate #COVID19 at home testing kit to be used by businesses, schools and individuals mentioned in @hartfordcourant https://t.co/taJDYKueIy

[NeuroEndoTalk @NeuroEndoTalk]

#WednesdayWisdom from @marklewismd about #Chromogranin-A .... is it consigned to the bin? What are the up and coming #biomarkers? Where does the future lie?
#LetsTalkNETS #MedTwitter #NeuroEndoTwitter
@CarcinoidNETs
@NANETS1
@CureNETs
@AmendInfo
@amensupport

[Mark Kidd @RNAnexus]

It’s that damn NETest again! @NANETS1 @RonnyAllan1 @marklewismd @PamelaKunzMD @spartelli @KitzAlexandra

[Mark Kidd @RNAnexus]

Great discussion/QA on NETest and PRRT SIO NANETS! @NANETS1 @RonnyAllan1

[Mark Kidd @RNAnexus]

Lots of interest @NANETS1 in a circulating molecule tool to predict PRRT! @PamelaKunzMD @marklewismd @lisabodei

[Mark Kidd @RNAnexus]

Some nice questions regarding NETest and PPQ

[Mark Kidd @RNAnexus]

@PamelaKunzMD @MustafaRaoofMD @AGangiMD @DanengLi @XKeutgen @jdeandradeMD @jgong15 @laleh_melstrom @drsuswarner @TheNotoriousHPB @SyedAAhmad5 Probably as important to be able to accurately assess when patient is progressing.

[NeuroEndoTalk @NeuroEndoTalk]

Date for your diary. Talk from @marklewismd and others.
#MedTwitter #letstalk

[Mark Kidd @RNAnexus]

@AmanChauhanMD @NVijayvergiaMD @PamelaKunzMD @helops79 @OncoThor @marklewismd @HKennecke @OncJournal Meta analysis. Autocorrect is so much fun!

[Mark Kidd @RNAnexus]

@AmanChauhanMD @NVijayvergiaMD @PamelaKunzMD @helops79 @OncoThor @marklewismd @HKennecke @OncJournal Lots of prospective data and @AmanChauhanMD is correct. Look at Liu et al. You may also want to view Prof Öberg’s paper in the Annals. Powerful mes-analysis confirms multiple utility.

[Mark Kidd @RNAnexus]

Thanks @AmanChauhanMD This should be an interesting study

[Aman Chauhan @AmanChauhanMD]

@NVijayvergiaMD @PamelaKunzMD @helops79 @OncoThor @marklewismd @HKennecke Unfortunately, I do not have experience with NETEST. We are going to evaluate it in our ongoing prospective clinical trial as exploratory endpoint NCT04234568 Lots of strong data already published in favor however check out Dr Liu's @OncJournal paper for practical aspects.

[Mark Kidd @RNAnexus]

My amazing sister!

[Odile Kidd @OdileKidd]

So this is pre lockdown collaborative work with scientist and principal curator of mammals ⁦@NHM_London⁩ I’m excited to finish it.

[NeuroEndoTalk @NeuroEndoTalk]

Today's expert opinion - we again hear from Prof Kjell Öberg from
@UU_University
We need #biomarkers for earlier diagnosis of NETs... how can we find better targets and what are you seeing as the best potential target?
#LetsTalkNets

[Mark Kidd @RNAnexus]

Excellent idea @NeuroEndoTalk What do you think? @enetwerkbe @pashtoonkasi @marklewismd @AmanChauhanMD @RonnyAllan1 @HKennecke @OncoThor @WrenLabs @GodelNet

[NeuroEndoTalk @NeuroEndoTalk]

🛎️Over the next while we will be sharing some NET words of wisdom...
First up...Prof Kjell Öberg from @UU_University shares his wisdom on what he sees are the challenges with #Neuroendocrine tumors.

What are you trying to do in your clinic and lab to overcome these?

#NETs

[Mark Kidd @RNAnexus]

Brilliant!

[Wren Laboratories @WrenLabs]

Wren Laboratories is now offering COVID-19 testing. We have developed a PCR-based test to detect SARS-CoV-2. Please contact us directly if you are interested!

[Mark Kidd @RNAnexus]

Thanks @cives_mauro. Once a diagnosis is made, the trajectory (speed/responsiveness to therapy) of the disease is an important focus.

[Mauro Cives @cives_mauro]

The NETest has exceptional sensitivity in NET patients: what is the optimal way to use this test in the clinical arena? @altoubaht @RNAnexus

https://t.co/8SkUBLbO9i